Usefulness of Contrast-Enhanced Magnetic Resonance Imaging in the Prediction of Myocardial Viability after Acute Myocardial Infarction.
10.4070/kcj.2000.30.10.1257
- Author:
Seung Eun JUNG
;
Ho Joong YOUN
;
Wook Sung CHUNG
;
Seong Tai HAHN
;
Soon Jo HONG
;
Choon Yeol KIM
- Publication Type:Original Article
- MeSH:
Echocardiography;
Follow-Up Studies;
Gadolinium;
Humans;
Magnetic Resonance Imaging*;
Myocardial Infarction*;
Myocardium
- From:Korean Circulation Journal
2000;30(10):1257-1263
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study was to evaluate the utility of contrast-enhanced MRI with first-pass and delayed images in prediction of myocardial viability after acute myocardial infarction. MATERIALS AND METHODS: Ten patients (M:F=:4, mean age =6 5 years) with acute myocardial infarction underwent first-pass image after bolus injection of gadolinium (one image/sec for 120sec)and delayed image (7 2 minutes later). According to 60 segments on midventricular level, the assessment of MRI were concerned about location of lesion, depth of lesion, enhancement on first-pass image and enhancement pattern on delayed image. MRI findings were compared with wall motion on resting echocardiography and stress or follow-up echocardiography. RESULTS: 1) MRI findings were classified into 4 types: normal enhancement on first-pass and delayed images (type 1), normal enhancement on first-pass image and nontransmural hyperenhancement on delayed image (type 2), non-transmural enhancing defect on first-pass image and transmural enhancement with endocardial non-enhancing defect on delayed image (type 3), and transmural enhancing defect on first-pass image and transmural hyperenhancement on delayed image (type 4).2) Type 2 suggested viable myocardium and type 3 had high porbability of viability. Type was compatible with non-viable myocardium. CONCLUSION: Enhancing defect on first-pass image and involving thickness on both the first-pass image and delayed image in contrast enhanced MRI may predict myocardial viability.
